These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23804222)

  • 41. Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.
    Kwakkenbos L; Thombs BD; Khanna D; Carrier ME; Baron M; Furst DE; Gottesman K; van den Hoogen F; Malcarne VL; Mayes MD; Mouthon L; Nielson WR; Poiraudeau S; Riggs R; Sauvé M; Wigley F; Hudson M; Bartlett SJ;
    Rheumatology (Oxford); 2017 Aug; 56(8):1302-1311. PubMed ID: 28431140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma.
    Matsuura E; Ohta A; Kanegae F; Haruda Y; Ushiyama O; Koarada S; Togashi R; Tada Y; Suzuki N; Nagasawa K
    J Rheumatol; 2003 Aug; 30(8):1782-7. PubMed ID: 12913935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the itch severity scale.
    Zachariae R; Lei U; Haedersdal M; Zachariae C
    Acta Derm Venereol; 2012 Sep; 92(5):508-14. PubMed ID: 22002738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construct validity of the Patient-Reported Outcomes Measurement Information System gastrointestinal symptom scales in systemic sclerosis.
    Nagaraja V; Hays RD; Khanna PP; Spiegel BM; Chang L; Melmed GY; Bolus R; Khanna D
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1725-30. PubMed ID: 24692332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
    Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality.
    Horsley-Silva JL; Umar SB; Vela MF; Griffing WL; Parish JM; DiBaise JK; Crowell MD
    Dis Esophagus; 2019 May; 32(5):. PubMed ID: 30715227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre.
    Thoua NM; Bunce C; Brough G; Forbes A; Emmanuel AV; Denton CP
    Rheumatology (Oxford); 2010 Sep; 49(9):1770-5. PubMed ID: 20530510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low socioeconomic status (measured by education) and outcomes in systemic sclerosis: data from the Canadian Scleroderma Research Group.
    Mansour S; Bonner A; Muangchan C; Hudson M; Baron M; Pope JE;
    J Rheumatol; 2013 Apr; 40(4):447-54. PubMed ID: 23418377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.
    Azar M; Rice DB; Kwakkenbos L; Carrier ME; Shrier I; Bartlett SJ; Hudson M; Mouthon L; Poiraudeau S; van den Ende CHM; Johnson SR; Rodriguez Reyna TS; Schouffoer AA; Welling J; Thombs BD;
    Disabil Rehabil; 2018 Aug; 40(17):1997-2003. PubMed ID: 28478701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
    Hong P; Pope JE; Ouimet JM; Rullan E; Seibold JR
    J Rheumatol; 2004 Mar; 31(3):508-13. PubMed ID: 14994396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II.
    Hudson M; Thombs BD; Steele R; Watterson R; Taillefer S; Baron M;
    Arthritis Rheum; 2008 Feb; 59(2):279-84. PubMed ID: 18240196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cigarette smoking in patients with systemic sclerosis.
    Hudson M; Lo E; Lu Y; Hercz D; Baron M; Steele R;
    Arthritis Rheum; 2011 Jan; 63(1):230-8. PubMed ID: 20936633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis.
    Omair MA; Lee P
    J Rheumatol; 2012 May; 39(5):992-6. PubMed ID: 22467930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pain grade and sleep disturbance in older adults: evaluation the role of pain, and stress for depressed and non-depressed individuals.
    Eslami V; Zimmerman ME; Grewal T; Katz M; Lipton RB
    Int J Geriatr Psychiatry; 2016 May; 31(5):450-7. PubMed ID: 26422058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis.
    Ljosaa TM; Mork C; Stubhaug A; Moum T; Wahl AK
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):29-35. PubMed ID: 21385220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.